Espana F, Aznar J, Estelles A
J Lab Clin Med. 1982 Nov;100(5):756-70.
Fibrinolytic studies in gamma G fractions of three Fletcher factor-deficient plasmas (functionally deficient in prekallikrein) revealed weak or no factor XII-independent activator activity. Two of the three Fletcher trait patients showed no plasminogen activator activity in clot lysis, fibrin plate, and amidolytic assays. The third patient showed no activator activity as determined by clot lysis and amidolytic assays but gave 10% of the activator activity detected in normal undiluted gamma G fraction in absence of HFf when determined by fibrin plate assay. Normal plasma gamma G fractions showed detectable and significant plasminogen activator activity. These fractions did not contain kallikrein or activated factor XI activities, thus indicating that the activator activity could not be attributed to the presence in these fractions or trace of these activated factors. Furthermore, factor XI-deficient plasma gamma G fraction, which was shown to contain no activated prekallikrein, showed normal plasminogen activator activity. Finally, specific antibodies to prekallikrein were shown not to quench the activity of plasminogen activator present in normal plasma gamma fraction. A double genetic deficiency to explain the absence in Fletcher factor-deficient plasma gamma G fractions of both prekallikrein proactivator and activator activities is not likely. Thus plasma prekallikrein, besides being a known plasminogen proactivator, appears to be required for the expression of a plasminogen activator activity.
对三份 Fletcher 因子缺乏血浆(功能上缺乏前激肽释放酶)的γG 组分进行的纤溶研究显示,因子 XII 非依赖性激活剂活性较弱或无此活性。三位 Fletcher 性状患者中的两位在凝块溶解、纤维蛋白平板和酰胺水解试验中均未显示纤溶酶原激活剂活性。第三位患者在凝块溶解和酰胺水解试验中未显示激活剂活性,但通过纤维蛋白平板试验测定,在不存在 HFf 的情况下,其激活剂活性为正常未稀释γG 组分中检测到的激活剂活性的 10%。正常血浆γG 组分显示出可检测到的显著纤溶酶原激活剂活性。这些组分不含有激肽释放酶或活化的因子 XI 活性,因此表明激活剂活性不能归因于这些组分中存在或微量存在这些活化因子。此外,已证明不含活化前激肽释放酶的因子 XI 缺乏血浆γG 组分显示出正常的纤溶酶原激活剂活性。最后,已证明抗前激肽释放酶的特异性抗体不能抑制正常血浆γ组分中存在的纤溶酶原激活剂的活性。不太可能存在双重基因缺陷来解释 Fletcher 因子缺乏血浆γG 组分中前激肽释放酶前激活剂和激活剂活性均缺失的情况。因此,血浆前激肽释放酶除了是一种已知的纤溶酶原前激活剂外,似乎还是纤溶酶原激活剂活性表达所必需的。